Dividend Shares
2 wonderful ASX dividend shares I’d buy in March 2026
I’m always on the hunt for quality ASX dividend shares at a good price. I’m going to talk about two that look wonderful buys today.
March 13, 2026
Big money is not in the buying or selling, but in the waiting.
For my own portfolio, I like to find ASX shares that are growing their dividends. Growth is an essential part of the dividend equation for me. I want to see that the dividend increases are funded by growing earnings and/or growing underlying asset values. I also have a portion of my portfolio invested in an ETF that picks undervalued global businesses with strong competitive advantages.
For Rask Media, I have an interest in covering technology (and tech-related) businesses with a global growth story, as well as cyclical companies that are cheaply priced because they’re at a low point in the cycle, such as retailers and resource businesses which could benefit strongly in the medium-term.
I’m always on the hunt for quality ASX dividend shares at a good price. I’m going to talk about two that look wonderful buys today.
The Collins Foods Ltd (ASX:CKF) share price is up more than 6% after the KFC operator announced a sales update.
The Liontown Ltd (ASX:LTR) share price is in focus after the ASX lithium share reported its FY26 half-year result.
The GQG Partners Inc (ASX:GQG) share price is down 5% after the fund manager gave its February 2026 monthly update.
The DroneShield Ltd (ASX:DRO) share price is under the spotlight after the company announced European manufacturing news.
Exchange-traded funds (ETFs) are a great way to invest in the share market without being too exposed to one particular business (or sector).
There are a number of appealing bargains out there on the ASX share market. I think investors have lots of great options to buy this month.
The Commonwealth Bank of Australia (ASX:CBA) share price is down 3% amid reports that it has reportedly referred loan fraud to the police.
The CSL Ltd (ASX: CSL) share price is up more than 2% after the ASX biotech share announced a vaccine agreement to supply Canada.
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
Here you go: A $50,000 per year passive income special report
Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.
Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.
Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.